DuPont de Nemours (NYSE:DD – Get Free Report) had its target price increased by equities research analysts at Jefferies Financial Group from $51.00 to $59.00 in a research note issued on Wednesday, MarketBeat.com reports. The firm currently has a “buy” rating on the basic materials company’s stock. Jefferies Financial Group’s target price would suggest a potential upside of 19.57% from the company’s current price.
DD has been the subject of several other reports. Wall Street Zen raised shares of DuPont de Nemours to a “hold” rating in a report on Saturday, January 10th. Royal Bank Of Canada lifted their price objective on DuPont de Nemours from $48.00 to $51.00 and gave the company an “outperform” rating in a research note on Wednesday, January 21st. BMO Capital Markets decreased their target price on DuPont de Nemours from $104.00 to $50.00 and set an “outperform” rating on the stock in a research note on Monday, November 3rd. Morgan Stanley lowered their price target on DuPont de Nemours from $80.00 to $44.00 in a report on Monday, November 10th. Finally, Citigroup lifted their price target on DuPont de Nemours from $47.00 to $50.00 and gave the company a “buy” rating in a research report on Tuesday, February 3rd. Twelve research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, DuPont de Nemours presently has an average rating of “Moderate Buy” and an average price target of $50.46.
View Our Latest Analysis on DuPont de Nemours
DuPont de Nemours Stock Down 4.2%
DuPont de Nemours (NYSE:DD – Get Free Report) last announced its quarterly earnings results on Tuesday, February 10th. The basic materials company reported $0.46 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.03. DuPont de Nemours had a positive return on equity of 7.37% and a negative net margin of 7.03%.The firm had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.69 billion. During the same period in the prior year, the business posted $1.13 earnings per share. The company’s revenue was up .2% on a year-over-year basis. DuPont de Nemours has set its FY 2026 guidance at 2.250-2.300 EPS and its Q1 2026 guidance at 0.480-0.480 EPS. Research analysts anticipate that DuPont de Nemours will post 4.38 earnings per share for the current fiscal year.
DuPont de Nemours announced that its Board of Directors has initiated a stock buyback program on Thursday, November 6th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the basic materials company to reacquire up to 12.2% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s leadership believes its stock is undervalued.
Insider Transactions at DuPont de Nemours
In other news, CEO Lori Koch sold 9,011 shares of the stock in a transaction dated Friday, November 28th. The stock was sold at an average price of $39.46, for a total transaction of $355,574.06. Following the transaction, the chief executive officer directly owned 288,326 shares in the company, valued at approximately $11,377,343.96. This represents a 3.03% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Erik T. Hoover sold 6,005 shares of the firm’s stock in a transaction dated Friday, November 28th. The shares were sold at an average price of $39.79, for a total value of $238,938.95. Following the transaction, the senior vice president directly owned 112,101 shares in the company, valued at approximately $4,460,498.79. This represents a 5.08% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.61% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On DuPont de Nemours
A number of institutional investors have recently made changes to their positions in DD. Vanguard Group Inc. lifted its stake in DuPont de Nemours by 6.7% in the third quarter. Vanguard Group Inc. now owns 50,867,267 shares of the basic materials company’s stock worth $3,962,560,000 after purchasing an additional 3,203,044 shares during the last quarter. State Street Corp grew its stake in shares of DuPont de Nemours by 4.8% during the second quarter. State Street Corp now owns 18,363,975 shares of the basic materials company’s stock valued at $1,259,585,000 after buying an additional 842,852 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of DuPont de Nemours by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 11,019,892 shares of the basic materials company’s stock worth $441,285,000 after buying an additional 74,355 shares during the period. Nuveen LLC lifted its stake in shares of DuPont de Nemours by 18.9% in the 4th quarter. Nuveen LLC now owns 10,662,674 shares of the basic materials company’s stock valued at $428,639,000 after acquiring an additional 1,695,097 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. boosted its holdings in DuPont de Nemours by 12,133.4% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 9,614,878 shares of the basic materials company’s stock valued at $365,921,000 after acquiring an additional 9,536,283 shares during the period. Hedge funds and other institutional investors own 73.96% of the company’s stock.
DuPont de Nemours News Summary
Here are the key news stories impacting DuPont de Nemours this week:
- Positive Sentiment: Multiple major brokers raised price targets and kept buy/overweight calls (Citigroup, Jefferies, UBS, Wells Fargo, KeyCorp, BMO, Wolfe), boosting upside thesis and supporting the stock’s recent rally. Wolfe Research Raises PT
- Positive Sentiment: DuPont reported better‑than‑expected Q4 results and provided FY guidance, which pushed the shares to a one‑year high and underpins the upgrades. Q4 Results & Guidance
- Positive Sentiment: Product recognition: DuPont’s FilmTec™ Fortilife™ XC160UHP reverse‑osmosis element was named an Edison Awards finalist — a modest positive for long‑term growth in water/wastewater markets. Edison Awards Finalist
- Neutral Sentiment: Morgan Stanley remains on a hold rating for DD, which tempers the otherwise bullish analyst momentum and gives some investors pause. Morgan Stanley Hold
- Neutral Sentiment: Several retail/investor pieces question whether the recent run makes DD less attractive near‑term (“Is it too late…”), highlighting valuation concerns that can limit further immediate buying. Valuation Commentary
- Negative Sentiment: Net effect today: profit‑taking and selling into strength after the multi‑broker upgrade wave and the one‑year high—mixed analyst signals (some holds/valuation cautions) left the stock vulnerable to a pullback on higher volume.
About DuPont de Nemours
DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.
DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.
See Also
- Five stocks we like better than DuPont de Nemours
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.
